Study on the spatial architecture of p53, MDM2, and p14ARF containing complexes

Molecular Biotechnology

Volumn 41, Issue 3, 2009, Pages 270-277

  Savchenko, Andrej ^a   Yurchenko, Mariya ^b   Snopok, Boris ^a   Kashuba, Elena ^c  

^a INSTITUTE OF SEMICONDUCTOR PHYSICS   (Ukraine)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Co localization; Spatial organization; SPR; Supramolecular protein complexes; Ternary complex

Indexed keywords

CO-LOCALIZATION; SPATIAL ORGANIZATION; SPR; SUPRAMOLECULAR PROTEIN COMPLEXES; TERNARY COMPLEX;

BINDING ENERGY; BINDING SITES; SUPRAMOLECULAR CHEMISTRY; SURFACE PLASMON RESONANCE;

COBALT COMPOUNDS;

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN MDM2; PROTEIN P53; MDM2 PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; STAPHYLOCOCCUS PROTEIN A;

ARTICLE; COMPLEX FORMATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; CELL STRAIN HCT116; CHEMISTRY; FLUORESCENCE MICROSCOPY; METABOLISM; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE;

HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MDM2; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL PROTEIN A; SURFACE PLASMON RESONANCE; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67949120479     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12033-008-9116-x     Document Type: Article

References (26)

1. J Momand GP Zambetti DC Olson D George AJ Levine 1992 The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 6 1237 1245 10.1016/0092-8674(92)90644-R 10.1016/0092-8674(92)90644-R
2. C Prives PA Hall 1999 The p53 pathway The Journal of Pathology 187 112 126 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3 1:CAS:528:DyaK1MXmvVKrtQ%3D%3D (Pubitemid 29009841)
3. UM Moll O Petrenko 2003 The MDM2-p53 interaction Molecular Cancer Research 1 1001 1008 1:CAS:528:DC%2BD2cXns1Gl
4. S Stone P Jiang P Dayananth SV Tavtigian H Katcher D Parry G Peters A Kamb 1995 Complex structure and regulation of the P16 (MTS1) locus Cancer Research 55 2988 2994 1:CAS:528:DyaK2MXmvVyisbc%3D
5. L Mao A Merlo G Bedi GI Shapiro CD Edwards BJ Rollins D Sidransky 1995 A novel p16INK4A transcript Cancer Research 55 2995 2997 1:CAS:528: DyaK2MXmvVyitr4%3D
6. Y Zhang Y Xiong WG Yarbrough 1998 ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways Cell 92 725 734 10.1016/S0092-8674(00)81401-4 10.1016/S0092-8674(00)81401-4 1:CAS:528:DyaK1cXit1KlsLw%3D (Pubitemid 28155312)
7. T Kamijo JD Weber G Zambetti F Zindy MF Roussel CJ Sherr 1998 Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2 Proceedings of the National Academy of Sciences of the United States of America 95 8292 8297 10.1073/pnas.95.14.8292 10.1073/pnas.95.14.8292 1:CAS:528:DyaK1cXks1Slu7g%3D (Pubitemid 28326106)
8. E Kashuba K Mattsson K Pokrovskaja C Kiss M Protopopova B Ehlin-Henriksson G Klein L Szekely 2003 EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells International Journal of Cancer 105 644 653 10.1002/ijc.11124 10.1002/ijc.11124 1:CAS:528:DC%2BD3sXkvFSgs7w%3D (Pubitemid 36687732)
9. E Kashuba K Mattsson G Klein L Szekely 2003 p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes Molecular Cancer 2 18 10.1186/1476-4598-2-18 10.1186/1476-4598-2-18 (Pubitemid 38751479)
10. B Snopok M Yurchenko L Szekely G Klein E Kashuba 2006 SPR based immuno-capturing approach for interfacial sensing architecture: mapping of MRS18-2 binding site on retinoblastoma protein Analytical and Bioanalytical Chemistry 386 2063 2073 10.1007/s00216-006-0867-6 10.1007/s00216-006-0867-6 1:CAS:528:DC%2BD28Xht1Cmsb3I (Pubitemid 44777717)
11. H Shimizu LR Burch AJ Smith D Dornan M Wallace KL Ball TR Hupp 2002 The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo The Journal of Biological Chemistry 277 28446 28458 10.1074/jbc.M202296200 10.1074/jbc.M202296200 1:CAS:528:DC%2BD38XmsVGqsbc%3D (Pubitemid 41079269)
12. CH Arrowsmith 1999 Structure and function in the p53 family Cell Death and Differentiation 6 1169 1173 10.1038/sj.cdd.4400619 10.1038/sj.cdd.4400619 1:CAS:528:DC%2BD3cXhtV2rtbg%3D
13. P Chene 2001 The role of tetramerization in p53 function Oncogene 20 2611 2617 10.1038/sj.onc.1204373 10.1038/sj.onc.1204373 1:CAS:528: DC%2BD3MXktVWnuro%3D (Pubitemid 32525291)
14. B Bothner WS Lewis EL DiGiammarino JD Weber SJ Bothner RW Kriwacki 2001 Defining the molecular basis of Arf and Hdm2 interactions Journal of Molecular Biology 314 263 277 10.1006/jmbi.2001.5110 10.1006/jmbi.2001.5110 1:CAS:528:DC%2BD3MXosFGgt7g%3D (Pubitemid 33105092)
15. M Oren 2003 Decision making by p53: life, death and cancer Cell Death and Differentiation 10 431 442 10.1038/sj.cdd.4401183 10.1038/sj.cdd.4401183 1:CAS:528:DC%2BD3sXjt1GjsLg%3D (Pubitemid 36626355)
16. SW Chi SH Lee DH Kim MJ Ahn JS Kim JY Woo T Torizawa M Kainosho KH Han 2005 Structural details on mdm2-p53 interaction The Journal of Biological Chemistry 280 38795 38802 10.1074/jbc.M508578200 10.1074/jbc.M508578200 1:CAS:528:DC%2BD2MXht1SktLnI (Pubitemid 43853782)
17. S Uhrinova D Uhrin H Powers K Watt D Zheleva P Fischer C McInnes PN Barlow 2005 Structure of free MDM2 N-terminal domain reveals conformational adjustments that accompany p53-binding Journal of Molecular Biology 350 587 598 10.1016/j.jmb.2005.05.010 10.1016/j.jmb.2005.05.010 1:CAS:528: DC%2BD2MXlsFGgu7o%3D (Pubitemid 40828916)
18. EL DiGiammarino I Filippov JD Weber B Bothner RW Kriwacki 2001 Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein Biochemistry 40 2379 2386 10.1021/bi0024005 10.1021/bi0024005 1:CAS:528:DC%2BD3MXms12ktA%3D%3D (Pubitemid 32171710)
19. AL Okorokov MB Sherman C Plisson V Grinkevich K Sigmundsson G Selivanova J Milner EV Orlova 2006 The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity The EMBO Journal 25 5191 5200 10.1038/sj.emboj.7601382 10.1038/sj.emboj.7601382 1:CAS:528:DC%2BD28XhtFChsrzF (Pubitemid 44658536)
20. T Soussi 2000 p53 Antibodies in the sera of patients with various types of cancer: a review Cancer Research 60 1777 1788 1:CAS:528:DC%2BD3cXisVyntLc%3D
21. B Vojtesek H Dolezalova L Lauerova M Svitakova P Havlis J Kovarik CA Midgley DP Lane 1995 Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein Oncogene 10 389 393 1:CAS:528:DyaK2MXjtlShtL0%3D
22. K Lim JX Ho K Keeling GL Gilliland X Ji F Ruker DC Carter 1994 Three-dimensional structure of Schistosoma japonicum glutathione S-transferase fused with a six-amino acid conserved neutralizing epitope of gp41 from HIV Protein Science 3 2233 2244 1:CAS:528:DyaK2MXjslajtbw%3D 10.1002/pro.5560031209
23. MS Lindstrom U Klangby R Inoue P Pisa KG Wiman CE Asker 2000 Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus Experimental Cell Research 256 400 410 10.1006/excr.2000.4854 10.1006/excr.2000.4854 1:CAS:528:DC%2BD3cXisFelu78%3D (Pubitemid 30244199)
24. T Sano T Hikino Q Xue T Saito K Kashiwabara T Oyama T Nakajima 2000 Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma Pathology International 50 709 716 10.1046/j.1440-1827.2000.01109.x 10.1046/j.1440-1827.2000.01109.x 1:CAS:528:DC%2BD3cXns1Klt7o%3D (Pubitemid 30765153)
25. MV Poyurovsky X Jacq C Ma O Karni-Schmidt PJ Parker M Chalfie JL Manley C Prives 2003 Nucleotide binding by the Mdm2 RING domain facilitates Arf-independent Mdm2 nucleolar localization Molecular Cell 12 875 887 10.1016/S1097-2765(03)00400-3 10.1016/S1097-2765(03)00400-3 1:CAS:528: DC%2BD3sXovVKjtbs%3D (Pubitemid 37352781)
26. C Korgaonkar J Hagen V Tompkins AA Frazier C Allamargot FW Quelle DE Quelle 2005 Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function Molecular and Cellular Biology 25 1258 1271 10.1128/MCB.25.4.1258-1271. 2005 10.1128/MCB.25.4.1258-1271.2005 1:CAS:528:DC%2BD2MXhs1Kgsb8%3D (Pubitemid 40204905)